Related Experiment Video
Updated: Jun 1, 2026

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
C-Myb function in the vessel wall
Kelly A Farrell1, Sarah B Withers, Cathy M Holt
1Core Technology Facility, University of Manchester, Manchester, UK.
Abstract:
C-Myb is a DNA-binding transcription factor that functions in apoptosis, proliferation and differentiation. The role of c-Myb in vascular injury has been investigated previously both in vitro and in vivo, where knock-down of c-Myb is known to lead to a reduction in proliferation and an increase in apoptosis of vascular smooth muscle cells (VSMCs). Reduction of c-Myb activity has also been shown to decrease neointimal formation in vivo, by reducing VSMC proliferation. In contrast, over-expression of c-Myb in vivo leads to increased survival rates in certain cell types. This review will look mainly at studies investigating c-Myb function in the vasculature, and evidence of signalling interactions which may be considered with regard to c-Myb as a possible target in the treatment of vasculoproliferative diseases.
Insights
C-Myb, a transcription factor, plays a key role in vascular smooth muscle cell (VSMC) proliferation and apoptosis. Targeting c-Myb may offer new treatments for vasculoproliferative diseases.
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Cellular Biology
Background:
- C-Myb is a DNA-binding transcription factor regulating apoptosis, proliferation, and differentiation.
- Previous studies show c-Myb knockdown reduces vascular smooth muscle cell (VSMC) proliferation and increases apoptosis.
- Reduced c-Myb activity decreases neointimal formation by inhibiting VSMC proliferation.
Purpose of the Study:
- To review the function of c-Myb in vascular biology.
- To explore signaling interactions of c-Myb.
- To evaluate c-Myb as a potential therapeutic target for vasculoproliferative diseases.
Main Methods:
- Literature review of in vitro and in vivo studies on c-Myb in vascular injury.
- Analysis of studies investigating c-Myb's role in VSMC proliferation, apoptosis, and neointimal formation.
- Examination of signaling pathways involving c-Myb.
Main Results:
- C-Myb knockdown in VSMCs reduces proliferation and increases apoptosis.
- Reduced c-Myb activity inhibits neointimal hyperplasia in vivo.
- Overexpression of c-Myb can increase survival in specific cell types.
Conclusions:
- C-Myb is a critical regulator of VSMC behavior in vascular injury.
- Modulating c-Myb activity presents a potential therapeutic strategy for vasculoproliferative disorders.
- Further research into c-Myb signaling interactions is warranted for targeted therapies.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Structure of Blood Vessels
Overview of the Vascular System
Development of Blood Vessels
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...
Induced Pluripotent Stem Cells
Somatic cells are...

